4//SEC Filing
DUGAN RICHARD W 4
Accession 0000950170-24-063019
CIK 0001347178other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 4:53 PM ET
Size
7.0 KB
Accession
0000950170-24-063019
Insider Transaction Report
Form 4
DUGAN RICHARD W
Director
Transactions
- Award
Common Stock
2024-05-17+20,529→ 118,229 total - Award
Stock Option (Right to Buy)
2024-05-17+37,578→ 37,578 totalExercise: $5.48Exp: 2034-05-16→ Common Stock (37,578 underlying)
Footnotes (2)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 17, 2025, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.
- [F2]This option vests and becomes exercisable with respect to 100% of the option shares on May 17, 2025, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.
Documents
Issuer
Vanda Pharmaceuticals Inc.
CIK 0001347178
Entity typeother
Related Parties
1- filerCIK 0001263499
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 4:53 PM ET
- Size
- 7.0 KB